Document is current
Any future updates will be listed below
-
Authors
Kabra, Madhusudan
Ali, Shehzad
Sadeghian, Mona
Thamattoor, Maithreyi
MacDonald, Tim
Lenuweit, Nils
Sundell, Ulriika
Moscone, Michela
Larm, Heidi Holmström
Sharma, Radha
-
Funding
Funding for this research was provided by:
Indivior
- License Information
-
More Information
Article History
Received: 9 July 2025
Accepted: 25 November 2025
First Online: 9 December 2025
Declarations
:
: Madhusudan Kabra and Heidi Holmström Larm are employees of Indivior Ltd. Mona Sadeghian was an employee of Indivior Ltd. when the study was conducted. Tim MacDonald has previously received honoraria, fees or professional development funding/resources from Trexapharm, Servier, Lundbeck/Otsuka, Indivior, Camurus, Australian and New Zealand Mental Health Association, Aurora Health, Healthe Care, Gold Coast Primary Health Network, So What Research, TKW Health and GoMedical. Nils Lenuweit has previously received honoraria from Indivior Ltd and speaker fees from RE:CANNIS. Ulriika Sundell has previously received speaker fees by Turku University, Indivior Ltd., Abbvie Ltd, Kompleksi ra, and Finnish cardiology ra. Michela Moscone has no interests to disclose. Shehzad Ali, Maithreyi Thamattoor and Radha Sharma have received consulting fees from Indivior Ltd.
: The study was conducted in accordance with the ethical principles of the Declaration of Helsinki, International Council for Harmonization Good Clinical Practice guidelines and applicable regulatory requirements. All patients provided written informed consent in accordance with local requirements. The study received an IRB exemption (IRB ID#: BB2409RS-037).
